Life-2023-02 Study on the Efficacy of Growth Inhibitors After Endoscopic Treatment of Acute Esophagogastric Variceal Bleeding
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 33
- 试验地点
- 1
- 主要终点
- rebleeding rate after the endoscopic treatment in Group A at 1 month
研究概览
简要总结
Study on the efficacy of the growth inhibitors after endoscopic treatment of acute esophagogastric variceal bleeding
详细描述
Participants with acute esophagogastric variceal bleeding in 5 days and under stable status will be included in this study. All the patients will take CTP test to confirm the blood flow status of the portal vein before endoscopic treatment. After that they will be randomly divided into two groups: A. accept growth inhibitors after the endoscopic treatment for 5 days; B. no growth inhibitor will be applied after the treatment.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •acute esophagogastric bleeding with hepatic cirhosis;
- •stable status (no active bleeding)
排除标准
- •endoscopic test limitation;
- •previous acute esophagogastric bleeding treatment history;
- •pregnant;
- •Immunity disabled;
研究组 & 干预措施
Group A
Participants in this group will take growth inhibitors for 5 days after endoscopic treatment.
干预措施: Growth Inhibitor (Drug)
结局指标
主要结局
rebleeding rate after the endoscopic treatment in Group A at 1 month
时间窗: 1 month after the endoscopic treatment
record the rebleeding incidence in this group A; (Rate A1= the number of rebleeding participants/the number of all the participants)
rebleeding rate after the endoscopic treatment in Group B at 1 month
时间窗: 1 month after the endoscopic treatment
record the rebleeding incidence in this group B; (Rate B1= the number of rebleeding participants/the number of all the participants)
rebleeding rate after the endoscopic treatment in Group B at 3 months
时间窗: 3 months after the endoscopic treatment
record the rebleeding incidence in this group B; (Rate B2= the number of rebleeding participants/the number of all the participants)
rebleeding rate after the endoscopic treatment in Group A at 3 months
时间窗: 3 months after the endoscopic treatment
record the rebleeding incidence in this group A; (Rate A2= the number of rebleeding participants/the number of all the participants)
rebleeding rate after the endoscopic treatment in Group A at 6 months
时间窗: 6 months after the endoscopic treatment
record the rebleeding incidence in this group A; (Rate A3= the number of rebleeding participants/the number of all the participants)
rebleeding rate after the endoscopic treatment in Group B at 6 months
时间窗: 6 months after the endoscopic treatment
record the rebleeding incidence in this group B; (Rate B3= the number of rebleeding participants/the number of all the participants)
次要结局
未报告次要终点